Neurones NRO

PAR: NRO | ISIN: FR0004050250   24/12/2024
43,90 EUR (-0,68%)
(-0,68%)   24/12/2024

NEURONES: Organic growth up 12.3% over the first nine months of the year

PRESS INFORMATION
Heading: 3rd quarter 2023 revenues        Nanterre, November 8, 2023 (after trading)

Organic growth up 12.3% over the first nine months of the year

(not audited, in millions of euros)20222023growthof which organic
3rd quarter revenues158.9177+ 11.4%+ 11%
Total as at the end-September486545.7+ 12.3%+ 12.3%

Achievements

NEURONES posted double-digit organic growth in the 3rd quarter, as it has done over the nine-month period as a whole.

Employee turnover remained high, reflecting continued buoyant demand over the period.

The most notable increases are still in Digital projects, Consulting, User Experience, Business Process Management and Cybersecurity.

Over the nine-month period as a whole, operating profit * stood at 10.6% of revenues.

Outlook

NEURONES confirms its forecasts for 2023 as a whole:

  • revenues of more than €730 million,
  • operating profit of around 10%.

* not audited and after inclusion of 0.7% of expenses related to bonus shares.

About NEURONES
With over 6,700 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – SRD (deferred settlement) mid-caps
www.neurones.net

Press Relations:
O'Connection
Valérie Hackenheimer
Tel.: +33 (0)6 12 80 35 20

vhackenheimer@oconnection.fr


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net

Attachment


Mijn selecties